Furthermore, both the somatic mutation repertoire and the pattern of FISH alterations of BCL2, BCL6, and MYC genes suggest the development of the DLBCL by a linear evolution from an FL dominant clone (Figures 1 and 2; Supplementary Table S2). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.